← Back
Data updated: Mar 29, 2026
ACCORD HLTHCARE
OncologyCardiovascularNeurology
Generics
ACCORD HLTHCARE is a generic drug manufacturer focused on Oncology, Cardiovascular, Neurology.
1972
Since
138
Drugs
-
Trials
1748
Approved (2yr)
Key Drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
FINGOLIMOD HYDROCHLORIDE 2026-02-24
Labeling
LURASIDONE HYDROCHLORIDE 2026-02-24
Labeling
LURASIDONE HYDROCHLORIDE 2026-02-24
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 41%
17 drugs
Cardiovascular 29%
12 drugs
Neurology 17%
7 drugs
Gastroenterology 7%
3 drugs
Infectious Disease 5%
2 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology, Infectious Disease, Neurology
Pfizer big-pharma
Oncology, Infectious Disease, Gastroenterology
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Oncology
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular
Novo Nordisk big-pharma
Oncology, Cardiovascular, Infectious Disease, Neurology
Active (76)
DEHYDRATED ALCOHOL PERAMPANEL PEMETREXED DISODIUM LENALIDOMIDE FINGOLIMOD HYDROCHLORIDE VILAZODONE HYDROCHLORIDE FULVESTRANT CARMUSTINE TEMSIROLIMUS TERIFLUNOMIDE TADALAFIL TRIENTINE HYDROCHLORIDE PRASUGREL CLOFARABINE VIGABATRIN DALFAMPRIDINE OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL OSELTAMIVIR PHOSPHATE ROSUVASTATIN CALCIUM BIVALIRUDIN EPTIFIBATIDE TIGECYCLINE ARIPIPRAZOLE DAPTOMYCIN DEXMEDETOMIDINE HYDROCHLORIDE ERLOTINIB HYDROCHLORIDE SOLIFENACIN SUCCINATE CAPECITABINE AZACITIDINE RANOLAZINE DECITABINE ESOMEPRAZOLE SODIUM PHENYLEPHRINE HYDROCHLORIDE MYCOPHENOLATE SODIUM PIOGLITAZONE HYDROCHLORIDE IBANDRONATE SODIUM CISATRACURIUM BESYLATE PRESERVATIVE FREE CISATRACURIUM BESYLATE ATORVASTATIN CALCIUM PARICALCITOL GEMCITABINE HYDROCHLORIDE ANASTROZOLE TEMOZOLOMIDE TACROLIMUS LEVETIRACETAM EPLERENONE IRINOTECAN HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE SERTRALINE HYDROCHLORIDE SIMVASTATIN PRAVASTATIN SODIUM RAMIPRIL TOPIRAMATE LISINOPRIL TRAMADOL HYDROCHLORIDE LEVOTHYROXINE SODIUM BUSPIRONE HYDROCHLORIDE DOXAZOSIN MESYLATE CLOMIPHENE CITRATE NALTREXONE HYDROCHLORIDE CLONAZEPAM CLOZAPINE MITOMYCIN GLIPIZIDE ETOPOSIDE NALOXONE HYDROCHLORIDE CISPLATIN METHYLPHENIDATE HYDROCHLORIDE ACETAZOLAMIDE HYDROCHLOROTHIAZIDE SUCCINYLCHOLINE CHLORIDE FLUOROURACIL METHOTREXATE SODIUM PRESERVATIVE FREE METHOTREXATE SODIUM
Discontinued (55)
BUPROPION HYDROCHLORIDE MYCOPHENOLATE MOFETIL DILTIAZEM HYDROCHLORIDE AMLODIPINE BESYLATE GLYCOPYRROLATE TRAZODONE HYDROCHLORIDE ZOLEDRONIC ACID ATROPINE SULFATE CARBOPLATIN LACOSAMIDE FINASTERIDE ROPINIROLE HYDROCHLORIDE FLUOXETINE HYDROCHLORIDE OXALIPLATIN AMITRIPTYLINE HYDROCHLORIDE FUROSEMIDE QUETIAPINE FUMARATE LETROZOLE ALLOPURINOL ESCITALOPRAM OXALATE MONTELUKAST SODIUM PROGESTERONE FESOTERODINE FUMARATE CLOPIDOGREL BISULFATE PACLITAXEL ITRACONAZOLE PIRFENIDONE SPIRONOLACTONE FOSAPREPITANT DIMEGLUMINE ISOSORBIDE MONONITRATE METOPROLOL SUCCINATE CINACALCET HYDROCHLORIDE DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE HYDROXYCHLOROQUINE SULFATE METHOTREXATE DOCETAXEL AMLODIPINE AND OLMESARTAN MEDOXOMIL GLIMEPIRIDE DONEPEZIL HYDROCHLORIDE BICALUTAMIDE CARBIDOPA AND LEVODOPA DOFETILIDE BREXPIPRAZOLE CLOBAZAM DIMETHYL FUMARATE ENTECAVIR DODEX EZETIMIBE CABAZITAXEL BUSULFAN
+5 more
Company Info
- First Approval
- 1972-09-20
- Latest
- 2026-02-05
- Applications
- 163
FDA Sponsor Names
ACCORD HLTHCAREACCORD HLTHCARE INC